{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:25:15Z","timestamp":1781817915037,"version":"3.54.5"},"reference-count":202,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.jacc.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T15:01:54Z","timestamp":1342623714000},"page":"645-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":447,"title":["2012 ACCF\/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina\/Non\u2013ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)"],"prefix":"10.1016","volume":"60","author":[{"given":"Hani","family":"Jneid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Scott","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia D.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Donald E.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Ettinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Fesmire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore G.","family":"Ganiats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Michael","family":"Lincoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Philippides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Theroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette K.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Patrick","family":"Zidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2012.06.004_bib2","series-title":"Clinical Practice Guidelines We Can Trust","year":"2011"},{"key":"10.1016\/j.jacc.2012.06.004_bib3","series-title":"Finding What Works in Health Care: Standards for Systematic Reviews","year":"2011"},{"key":"10.1016\/j.jacc.2012.06.004_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2007.02.013","volume":"50","author":"Anderson","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib5","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2011.02.009","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib6","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.jacc.2011.02.011","volume":"57","author":"Wright","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib10","doi-asserted-by":"crossref","first-page":"d3527","DOI":"10.1136\/bmj.d3527","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"342","author":"James","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2012.06.004_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib13a","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib13b","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib13c","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"359","author":"Sacco","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib13d","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.082727","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes and a history of stroke or transient ischemic attack","author":"James","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib13e","author":"Sabatine"},{"key":"10.1016\/j.jacc.2012.06.004_bib13f","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.112.111930","article-title":"Beware of novel antiplatelet therapy in ACS patients with previous stroke","author":"Verheugt","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1503\/cmaj.090251","article-title":"The drug-drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Lau","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2012.06.004_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa0809171","article-title":"Cytochrome p-450 polymorphisms and response to clopidogrel","volume":"360","author":"Mega","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","article-title":"ACCF\/AHA clopidogrel clinical alert: approaches to the FDA \u201cboxed warning.\u201d","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.amjcard.2008.11.048","article-title":"Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis","volume":"103","author":"Giusti","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib23","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.109.865907","article-title":"Clopidogrel and the concept of high-risk pharmacokinetics","volume":"119","author":"Roden","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/eurheartj\/ehp041","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention","volume":"30","author":"Sibbing","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/tpj.2010.21","article-title":"Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis","volume":"11","author":"Sofi","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jacc.2012.06.004_bib27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G\u2192A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib28","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/CIRCULATIONAHA.109.851949","article-title":"Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes","volume":"119","author":"Mega","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib29","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehp157","article-title":"Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease","volume":"30","author":"Varenhorst","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib30","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib31","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1001\/jama.2011.1880","article-title":"CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis","volume":"306","author":"Holmes","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib34","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","article-title":"A population-based study of the drug interaction between proton pump inhibitors and clopidogrel","volume":"180","author":"Juurlink","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/j.jacc.2012.06.004_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O'Donoghue","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib37","unstructured":"Deleted in proof."},{"key":"10.1016\/j.jacc.2012.06.004_bib38","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib39","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1160\/TH08-12-0808","article-title":"Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel","volume":"101","author":"Sibbing","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2012.06.004_bib40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","article-title":"Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel","volume":"48","author":"Small","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jacc.2012.06.004_bib41","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib42","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib43","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","volume":"56","author":"Abraham","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib44","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/oxfordjournals.eurheartj.a015163","article-title":"Reperfusion strategies in acute myocardial infarction","volume":"18","author":"Boersma","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib46","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib47","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels: c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators","volume":"340","author":"Hamm","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib48","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(99)10285-X","article-title":"Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban: PRISM Study Investigators: Platelet Receptor Inhibition in Ischemic Syndrome Management","volume":"354","author":"Heeschen","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM199907293410503","article-title":"Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb\/IIIa receptors: Evaluation of Platelet IIb\/IIIa Inhibition in Stenting Investigators","volume":"341","author":"Lincoff","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib50","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes: the PURSUIT Trial Investigators: Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib52","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes","volume":"104","author":"Roffi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib53","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib54","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib55","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib56","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib58","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2012.06.004_bib60","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib61","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","article-title":"Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end points analysis from the ATACS trial: Antithrombotic Therapy in Acute Coronary Syndromes Research Group","volume":"89","author":"Cohen","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib63","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib64","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","article-title":"Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men","volume":"336","author":"Ridker","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib65","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","article-title":"Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease","volume":"336","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib67","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib68","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1001\/jama.292.24.3017","article-title":"Aspirin sensitivity: implications for patients with coronary artery disease","volume":"292","author":"Gollapudi","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib69","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib70","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial","volume":"357","author":"Simoons","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib71","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.0000046487.06811.5E","article-title":"Long-term results after the glycoprotein IIb\/IIIa inhibitor abciximab in unstable angina: one-year survival in the GUSTO IV-ACS (Global Use of Strategies To Open Occluded Coronary Arteries IV\u2013Acute Coronary Syndrome) Trial","volume":"107","author":"Ottervanger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib72","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0140-6736(99)07349-3","article-title":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib73","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2006.06.049","article-title":"Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting","volume":"48","author":"Cuisset","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib74","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.105.559088","volume":"112","author":"von Beckerath","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib75","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib76","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib77","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Stone","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib78","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib79","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease, I: treatments following myocardial infarction","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib80","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib81","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","article-title":"Assessment of the treatment effect of enoxaparin for unstable angina\/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib82","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib83","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2007.07.042","article-title":"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial","volume":"50","author":"Mehta","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib84","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1067\/mtc.2001.117838","article-title":"Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting","volume":"122","author":"Bizzarri","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl","key":"10.1016\/j.jacc.2012.06.004_bib85","first-page":"I286","article-title":"Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting","volume":"112","author":"Bybee","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib86","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/S0003-4975(00)02133-0","article-title":"Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients","volume":"70","author":"Dacey","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.06.004_bib87","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.CIR.77.6.1324","article-title":"Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study","volume":"77","author":"Goldman","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib88","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0003-4975(00)01343-6","article-title":"Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials: Improve Long-term Outcome with abciximab GP IIb\/IIIa blockade: Evaluation of Platelet IIb\/IIIa Inhibition in STENTing","volume":"70","author":"Lincoff","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.06.004_bib89","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2012.06.004_bib91","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0003-4975(00)01654-4","article-title":"Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT: Platelet Glycoprotein IIb\/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy","volume":"70","author":"Dyke","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.06.004_bib92","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0003-4975(99)01366-1","article-title":"Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery","volume":"69","author":"Clark","year":"2000","journal-title":"Ann Thorac Surg"},{"issue":"suppl I","key":"10.1016\/j.jacc.2012.06.004_bib93","first-page":"I19","article-title":"Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports","volume":"106","author":"Jones","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0003-4975(03)00190-5","article-title":"Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting","volume":"76","author":"Kincaid","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jacc.2012.06.004_bib95","first-page":"1107","article-title":"Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes","volume":"150","author":"Mehta","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib96","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib97","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ahj.2004.04.036","article-title":"Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale","volume":"148","author":"Stone","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib98","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib99","series-title":"Plavix (clopidogrel bisulfate) [package insert]","year":"2009"},{"key":"10.1016\/j.jacc.2012.06.004_bib100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ahj.2008.06.034","article-title":"Clopidogrel use and bleeding after coronary artery bypass graft surgery","volume":"156","author":"Kim","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib101","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/01.CIR.0000161383.06692.D4","volume":"111","author":"Patti","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib102","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0735-1097(90)90648-9","article-title":"Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty","volume":"15","author":"Knudtson","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib104","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0002-9149(01)02119-1","article-title":"Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention","volume":"88","author":"Roe","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib105","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/j.ahj.2005.02.023","article-title":"Exploring the role of enoxaparin in the management of high-risk patients with non-ST-elevation acute coronary syndromes: the SYNERGY trial","volume":"149","author":"Mahaffey","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib106","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib107","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib108","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","article-title":"Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial","volume":"358","author":"White","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib109","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib110","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib111","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"De Winter","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib112","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM198704163161603","article-title":"Comparison of medical and surgical treatment for unstable angina pectoris: results of a Veterans Administration Cooperative Study","volume":"316","author":"Luchi","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib113","doi-asserted-by":"crossref","first-page":"561","DOI":"10.7326\/0003-4819-126-7-199704010-00012","article-title":"Risk stratification after myocardial infarction","volume":"126","author":"Peterson","year":"1997","journal-title":"Ann Intern Med"},{"issue":"suppl","key":"10.1016\/j.jacc.2012.06.004_bib114","first-page":"III107","article-title":"The VA cooperative randomized study of surgery for coronary arterial occlusive disease II: subgroup with significant left main lesions","volume":"54","author":"Takaro","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.amjcard.2008.08.048","article-title":"Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis","volume":"103","author":"Bonello","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib116","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib117","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCULATIONAHA.108.812636","article-title":"Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up","volume":"119","author":"Marcucci","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib118","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1161\/01.CIR.0000130846.46168.03","article-title":"Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction","volume":"109","author":"Matetzky","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib119","first-page":"841","article-title":"Clopidogrel non-responsiveness and risk of cardiovascular morbidity: an updated meta-analysis","volume":"103","author":"Sofi","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2012.06.004_bib120","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib122","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\u201ccooling-off\u201d strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib123","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2009.1267","article-title":"Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial","volume":"302","author":"Montalescot","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib124","first-page":"1025","article-title":"The CAPTURE registry: predictors of outcomes in carotid artery stenting with embolic protection for high surgical risk patients in the early post-approval setting","volume":"70","author":"Gray","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2012.06.004_bib125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib126","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jacc.2009.11.026","volume":"55","author":"Damman","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib127","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/eurheartj\/ehn417","article-title":"Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study","volume":"30","author":"Jolly","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib128","doi-asserted-by":"crossref","first-page":"379","DOI":"10.7326\/0003-4819-150-6-200903170-00006","article-title":"Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding","volume":"150","author":"Steinhubl","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib129","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0002-9149(89)90752-2","article-title":"Decision analysis concerning the application of echocardiography to the diagnosis and treatment of mural thrombi after anterior wall acute myocardial infarction","volume":"64","author":"Weintraub","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib131","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0735-1097(93)90409-T","article-title":"Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis","volume":"22","author":"Vaitkus","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib132","doi-asserted-by":"crossref","first-page":"140S","DOI":"10.1378\/chest.95.2_Supplement.140S","article-title":"Antithrombotic therapy for cerebrovascular disorders","volume":"95","author":"Sherman","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2012.06.004_bib133","first-page":"77","article-title":"Mural thrombus in left ventricular aneurysm: incidence, role of angiography, and relation between anticoagulation and embolization","volume":"56","author":"Reeder","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2012.06.004_bib134","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/pgmj.72.854.731","article-title":"Intracardiac thrombus formation in cardiac impairment: the role of anticoagulant therapy","volume":"72","author":"Lip","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jacc.2012.06.004_bib135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0002-9343(83)90798-2","article-title":"Mural thrombi in myocardial infarctions: prospective evaluation by two-dimensional echocardiography","volume":"74","author":"Keating","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib136","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0735-1097(01)01587-X","volume":"38","author":"Fuster","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib137","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0002-8703(92)91069-D","article-title":"Antithrombotic therapy in left ventricular thrombosis and systemic embolism","volume":"123","author":"Cregler","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib138","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0735-1097(98)00006-0","article-title":"Warfarin anticoagulation and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction","volume":"31","author":"Al-Khadra","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib139","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib140","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/bmj.4.5627.366","article-title":"Dipyridamole: a controlled trial of its effect in acute myocardial infarction","volume":"4","author":"Gent","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.jacc.2012.06.004_bib141","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000024408.81821.32","article-title":"Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial","volume":"106","author":"Brouwer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib142","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/hc0502.103329","article-title":"Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study","volume":"105","author":"Fiore","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib143","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, aspirin, or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib144","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib146","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0140-6736(05)63824-X","article-title":"CARS trial: warfarin and thrombin generation: Coumadin Aspirin Reinfarction Study","volume":"350","author":"Peverill","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib147","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jacc.2003.08.050","article-title":"Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization","volume":"43","author":"Norhammar","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib148","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib149","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib150","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction","volume":"301","author":"Kosiborod","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib151","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1161\/01.CIR.99.20.2626","volume":"99","author":"Malmberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib152","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib153","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1016\/j.jacc.2004.07.014","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib154","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.jacc.2009.10.015","volume":"54","author":"Kushner","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib155","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jama.300.8.933","article-title":"Benefits and risks of tight glucose control in critically ill adults: a meta-analysis","volume":"300","author":"Wiener","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib156","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000160869.75810.98","article-title":"Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention","volume":"111","author":"Hochholzer","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib157","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2012.06.004_bib158","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.jacc.2009.01.041","article-title":"Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients","volume":"53","author":"Marfella","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib159","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ALN.0b013e31817dced3","article-title":"Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism","volume":"109","author":"Deedwania","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jacc.2012.06.004_bib160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/eurheartj\/ehm498","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology","volume":"29","author":"Rapezzi","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib161","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9149(02)02844-8","article-title":"Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (the TACTICS-TIMI 18 Trial)","volume":"90","author":"Januzzi","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib162","doi-asserted-by":"crossref","first-page":"563","DOI":"10.7326\/0003-4819-137-7-200210010-00007","article-title":"Acute myocardial infarction and renal dysfunction: a high-risk combination","volume":"137","author":"Wright","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib163","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-137-7-200210010-00006","article-title":"Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients","volume":"137","author":"Shlipak","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib164","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents","volume":"331","author":"Solomon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib165","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/ndt\/14.5.1064","article-title":"Does hydration prevent radiocontrast-induced acute renal failure?","volume":"14","author":"Erley","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacc.2012.06.004_bib166","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2007.03.058","article-title":"Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention","volume":"50","author":"Laskey","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib167","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0002-9149(02)02771-6","article-title":"Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose","volume":"90","author":"Freeman","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib168","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.05551008","article-title":"Early angiography in patients with chronic kidney disease: a collaborative systematic review","volume":"4","author":"Charytan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jacc.2012.06.004_bib169","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib170","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/RLI.0b013e31815f3172","article-title":"The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography","volume":"43","author":"Thomsen","year":"2008","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib171","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1161\/CIRCULATIONAHA.106.671644","article-title":"Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease","volume":"115","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib172","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2008.05.023","article-title":"Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography\/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial","volume":"156","author":"Rudnick","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib173","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2214\/AJR.07.3370","article-title":"The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure","volume":"191","author":"Kuhn","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2012.06.004_bib174","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jcin.2009.05.002","article-title":"The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials","volume":"2","author":"Reed","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2012.06.004_bib175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1148\/radiol.2501080833","article-title":"Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials","volume":"250","author":"Heinrich","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jacc.2012.06.004_bib176","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ahj.2009.08.016","article-title":"Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures","volume":"158","author":"Laskey","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2012.06.004_bib177","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/028418519303400118","article-title":"Effects of femoral arteriography and low osmolar contrast agents on renal function","volume":"34","author":"Nikonoff","year":"1993","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib178","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02758260","article-title":"Renal function and cardiac angiography","volume":"73","author":"Niboshi","year":"2006","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jacc.2012.06.004_bib179","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02552154","article-title":"Comparison of the nephrotoxicity between ioversol and iohexol","volume":"28","author":"Hayami","year":"1996","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jacc.2012.06.004_bib180","first-page":"133","article-title":"A comparative study of the nephrotoxicity of iohexol, iopamidol and ioxaglate in peripheral angiography","volume":"41","author":"Campbell","year":"1990","journal-title":"Can Assoc Radiol J"},{"key":"10.1016\/j.jacc.2012.06.004_bib181","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/sj.ki.5001887","article-title":"Renal failure in 57,925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media","volume":"70","author":"Liss","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacc.2012.06.004_bib182","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jacc.2004.06.075","article-title":"Contrast nephropathy: review focusing on prevention","volume":"44","author":"Maeder","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib183","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1378\/chest.114.6.1570","article-title":"PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction","volume":"114","author":"Taylor","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2012.06.004_bib184","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2214\/ajr.181.6.1811463","article-title":"Guidelines for contrast media from the European Society of Urogenital Radiology","volume":"181","author":"Thomsen","year":"2003","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacc.2012.06.004_bib185","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.106.687152","article-title":"Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies","volume":"115","author":"Briguori","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib186","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jcin.2009.07.015","article-title":"Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis","volume":"2","author":"Brown","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jacc.2012.06.004_bib187","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.amjcard.2007.03.098","article-title":"Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure","volume":"100","author":"Masuda","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib188","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib189","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1056\/NEJMoa054209","article-title":"N-acetylcysteine and contrast-induced nephropathy in primary angioplasty","volume":"354","author":"Marenzi","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib190","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.jacc.2009.08.091","volume":"55","author":"Thiele","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib191","doi-asserted-by":"crossref","first-page":"27K","DOI":"10.1016\/j.amjcard.2006.01.022","article-title":"Risk prediction of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib192","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2012.06.004_bib193","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib195","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","article-title":"Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2012.06.004_bib196","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1161\/CIRCULATIONAHA.108.191107","article-title":"ACC\/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"118","author":"Bonow","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib197","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.107.694141","article-title":"A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Henry","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib198","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/CIRCULATIONAHA.107.720946","article-title":"Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time","volume":"116","author":"Jacobs","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2012.06.004_bib199","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.jacc.2008.10.012","volume":"52","author":"Krumholz","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2012.06.004_bib200","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa073102","article-title":"A citywide protocol for primary PCI in ST-segment elevation myocardial infarction","volume":"358","author":"Le May","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2012.06.004_bib204","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/CIRCULATIONAHA.107.699934","article-title":"Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol","volume":"116","author":"Ting","year":"2007","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712019596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109712019596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:53:27Z","timestamp":1760014407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109712019596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":202,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0735109712019596"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2012.06.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718180332.793487048","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2012 ACCF\/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina\/Non\u2013ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2012.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}